Premium
Entecavir treatment may be associated with decreased libido in male patients with chronic hepatitis B: report of two cases
Author(s) -
Turker Kamuran,
Sonbahar Adil Emrah,
Serefoglu Ege Can,
Korkmaz Fidan Munire,
Kanarya Vardar Melek
Publication year - 2016
Publication title -
andrologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.633
H-Index - 59
eISSN - 1439-0272
pISSN - 0303-4569
DOI - 10.1111/and.12483
Subject(s) - entecavir , medicine , libido , chronic hepatitis , nausea , hepatitis b , side effect (computer science) , decreased libido , gastroenterology , immunology , lamivudine , virus , computer science , programming language
Summary Various types of drugs are being used to treat patients with chronic hepatitis B infection. However, these treatment modalities are not without side effects, which may result in decreased patient adherence. Entecavir is an oral reverse transcriptase inhibitor, which is widely used in patients with hepatitis B. Although headache, fatigue and nausea are well‐documented side effects of entecavir, its sexual side effects have not been reported yet. We here report on two male patients with chronic hepatitis B infection who reported decreased libido under entecavir treatment.